Kawarabayashi N, Seki S, Hatsuse K, Ohkawa T, Koike Y, Aihara T, Habu Y, Nakagawa R, Ami K, Hiraide H, Mochizuki H
Department of Surgery I, National Defense Medical College, Tokorozawa, Japan.
Hepatology. 2000 Nov;32(5):962-9. doi: 10.1053/jhep.2000.19362.
CD56(+)T cells and CD56(+)natural killer (NK) cells are abundant in the human liver. The aim of this study was the further characterization of these cells in the liver with or without hepatitis C virus (HCV) infection. Liver mononuclear cells (MNC) were isolated from liver specimens obtained from the patients during abdominal surgery. In addition to a flow cytometric analysis, liver MNC and PBMC were cultured with the immobilized anti-CD3 Ab, IL-2, or a combination of IL-2 and IL-12 and their IFN-gamma production and the antitumor cytotoxicity were assessed. The liver MNC of HCV (-) patients contained 20% CD56(+)T cells whereas the same proportions decreased to 11% in chronic hepatitis livers and to 5% in cirrhotic livers. The proportion of NK cells also decreased in the cirrhotic livers. On the other hand, the populations of these cells in PBMC did not significantly differ among patient groups. The IFN-gamma production and the cytotoxicity against K562 cells, Raji cells, and a hepatocellular carcinoma, HuH-7 cells, greatly decreased in the cirrhotic liver MNC. In contrast, the cytotoxicity in PBMC did not significantly differ among the patient groups and was lower than that in the liver MNC of HCV (-) patients. CD56(+)T cells and NK cells but not regular T cells purified from liver MNC cultured with cytokines showed potent cytotoxicities against HuH-7 cells. These results suggest that a decreased number of CD56(+)T cells and NK cells in cirrhotic livers may be related to their susceptibility to hepatocellular carcinoma.
CD56(+)T细胞和CD56(+)自然杀伤(NK)细胞在人类肝脏中大量存在。本研究的目的是进一步表征感染或未感染丙型肝炎病毒(HCV)的肝脏中的这些细胞。从腹部手术患者的肝脏标本中分离出肝脏单核细胞(MNC)。除了流式细胞术分析外,将肝脏MNC和外周血单核细胞(PBMC)与固定化抗CD3抗体、白细胞介素-2(IL-2)或IL-2与IL-12的组合一起培养,并评估它们的γ干扰素产生情况以及抗肿瘤细胞毒性。HCV(-)患者的肝脏MNC含有20%的CD56(+)T细胞,而在慢性肝炎肝脏中这一比例降至11%,在肝硬化肝脏中降至5%。NK细胞的比例在肝硬化肝脏中也有所下降。另一方面,这些细胞在外周血单核细胞中的数量在不同患者组之间没有显著差异。肝硬化肝脏MNC中针对K562细胞、Raji细胞和肝癌HuH-7细胞的γ干扰素产生和细胞毒性大大降低。相比之下,外周血单核细胞中的细胞毒性在不同患者组之间没有显著差异,并且低于HCV(-)患者肝脏MNC中的细胞毒性。从用细胞因子培养的肝脏MNC中纯化的CD56(+)T细胞和NK细胞而非常规T细胞对HuH-7细胞显示出强大的细胞毒性。这些结果表明,肝硬化肝脏中CD56(+)T细胞和NK细胞数量的减少可能与其对肝细胞癌的易感性有关。